Your activity: 6 p.v.

Nonpharmacologic management of Parkinson disease

Nonpharmacologic management of Parkinson disease
Authors:
Jori Fleisher, MD, MSCE
Daniel Tarsy, MD
Section Editor:
Howard I Hurtig, MD
Deputy Editor:
April F Eichler, MD, MPH
Literature review current through: Dec 2022. | This topic last updated: Oct 25, 2022.

INTRODUCTION — Parkinson disease (PD) is a chronic disorder that requires broad-based management including patient and family education, support group services, general wellness maintenance, exercise, and nutrition. Treatment of PD can be divided into nonpharmacologic, pharmacologic, and surgical therapy. A useful algorithm for the management of PD has been published by the American Academy of Neurology (AAN) [1].

This topic will review the nonpharmacologic management of PD. The pharmacologic treatment of PD and the treatment of comorbid problems associated with it are discussed separately. (See "Initial pharmacologic treatment of Parkinson disease" and "Management of nonmotor symptoms in Parkinson disease".)

EDUCATION — The prospect of having a chronic and progressive neurologic disease is frightening. Many individuals are familiar with PD and may even have had first-hand acquaintance with its disabling effects in an affected family member or friend. Education is essential in order to provide the patient and family with some understanding and control over the disorder. Education can combat the stigma and misinformation that often surround the disorder [2-4].

However, caution should be exercised in newly diagnosed patients with mild symptoms and an uncertain future with regard to progression; early overexposure to potentially disturbing material may be counterproductive. Focused education surrounding particular symptoms may be more effective and is available through books and other materials (see 'Information for patients' below) written for the lay audience, through national and regional PD organizations (table 1), which publish educational pamphlets and organize symposia for patients and families, and through the internet.

SUPPORT — The emotional and psychologic needs of the patient with PD and family should be addressed. Normal reactions of anger, depression, anxiety, and social and economic concerns often begin with the onset of the disease and evolve as it progresses. Support for the care partner is particularly important as he or she learns to cope with the increasing needs of the spouse or parent, or more rarely, a son or daughter [5]. Support groups are especially valuable for allowing interactions with other patients or families with similar experiences and for providing access to useful educational information [6].

For patients with early PD, referral to another affected patient or family may be less overwhelming than a large support group composed of patients with advanced disease. Patients and care partners can enroll in the online Parkinson's Buddy Network to connect with other individuals affected by PD. Early-onset PD groups also have been formed in some locales, and an early-onset PD handbook is available [7]. There are also some national support organizations, several of which have local chapters (table 1).

Referral of the patient and/or family to a psychologist or psychiatric social worker experienced in dealing with chronic illness may be appropriate in some cases. For many patients, disclosing the diagnosis is a source of concern, particularly among younger patients, employed patients, and those with younger children [8]. Social workers, psychologists, and other trained therapists can offer support and resources to aid in these challenging discussions. There are books available to help children of different ages understand the diagnosis of PD in a loved one, written by individuals with PD and by care partners [9-11]. In other instances, referral for legal, financial, or occupational counseling is indicated.

Social isolation — Patients with PD and their care partners are at risk for social isolation, particularly during later stages of disease or periods of home confinement. In a study conducted prior to the coronavirus disease 2019 (COVID-19) pandemic, researchers found that individuals with PD who reported having many friends had 21 percent fewer PD symptoms than those with few or no friends, and individuals identifying as lonely had a 55 percent higher PD symptom severity score than those denying loneliness [12]. Pandemic-imposed isolation has been associated with decreased quality of life, increased risk for mood disorders, decreased mobility, and worsening of motor function and symptom burden [13-17].

Social prescribing refers to connecting patients and care partners to sources of support within their own community, whether geographic, online, or related to a particular disease or even health system. Many social prescribing initiatives have been launched through the United Kingdom's National Health Service, the United States Department of Veterans Affairs, and individual health care institutions [18-21], including one PD-specific program launched during the COVID-19 pandemic [22]. Social prescribing may include lifestyle modifications such as diet and exercise, with connection to specific community resources, or may consist of referrals to support groups, self-management classes, volunteer opportunities, and community activities.

EXERCISE AND PHYSICAL THERAPY — Regular exercise promotes a feeling of physical and mental wellbeing; it is especially valuable due to the chronic nature of PD and its associated progressive motor limitations. In patients with PD, exercise may help to slow motor progression, improve nonmotor symptoms, and alleviate some secondary orthopedic effects of rigidity and flexed posture such as shoulder, hip, and back pain [23-28].

The available evidence suggests that regular aerobic exercise has a small positive impact on PD [25,29-34]. As an example, a randomized trial in patients with mild PD within five years of diagnosis assigned participants to high-intensity exercise, moderate-intensity exercise, or a waitlist control. High- and moderate-intensity participants engaged in four days per week of treadmill exercise for six months, achieving 80 to 85 or 60 to 65 percent of their maximum heart rate, respectively, compared with waitlist controls. The intervention met its feasibility goals, and after six months, there was a small but statistically significant difference in the change in Unified Parkinson's Disease Rating Scale motor score in the high-intensity group compared with controls [35].

Multiple studies also support tai chi as a beneficial form of exercise in patients with PD [36-39]. A randomized controlled trial of 195 subjects with mild to moderate PD found that a six-month program of twice-weekly tai chi training was superior to resistance training and stretching for improvement in measurements of postural stability, stride length, and functional reach [36]. There were fewer self-reported falls at six months for the tai chi group compared with the resistance training and stretching groups (62 versus 133 versus 186), and the difference was statistically significant for the comparison with the stretching group. In a meta-analysis that included 21 studies of individuals with PD, 15 of which were randomized trials (n = 735), tai chi/qigong was associated with small to medium improvements in most studied motor outcomes including the Unified Parkinson's Disease Rating Scale III, balance, Timed Up and Go testing, six-minute walk, and falls [37]. A subsequent randomized controlled trial compared the effects of an eight-week mindfulness yoga program to a stretching and resistance training program in individuals with mild to moderate PD [40]. Both yoga and stretching/resistance training demonstrated similar improvements in mobility and motor dysfunction, and yoga yielded additional benefits in anxiety, depression, and health-related quality of life.

Thus, exercises to improve balance, flexibility, and strength should be emphasized. Brisk walks, tai chi, swimming, and water aerobic exercises may be particularly useful, although available studies comparing the effectiveness of different interventions are not definitive [41,42]. Other modalities that may improve functional outcome for patients with PD include the following [24]:

Multidisciplinary rehabilitation with standard physical and occupational therapy components [43,44]

Use of compensation strategies to facilitate gait (eg, external auditory, proprioceptive, or visual cuing) [45,46]

Treadmill training [35,47-49]

Balance training and high-intensity resistance training [50,51]

High-intensity agility training [52]

Cued exercises with visual (mirror), auditory (metronome), and tactile feedback [53]

Active music therapy [54]

Dance therapy [55,56]

Lee Silverman Voice Treatment physical therapy program (LSVT-BIG) [57]

Many patients engaged in physical therapy gain lasting confidence and a sense of control over one aspect of the disease, especially if they have never engaged in physical activity in the past. Parkinson-specific exercise programs may also provide social support and camaraderie, separate from and complementary to the support options above [58,59]. Referral to a physical therapist or exercise group is a good way to get patients started in such activities.

SPEECH THERAPY — Dysarthria and hypophonia are common manifestations of PD, and small randomized trials support speech therapy as an intervention to improve speech volume [24,60-64].

Several techniques have been shown to be more effective than no treatment in small, nonblinded randomized trials in patients with PD. One technique employs speech therapy emphasizing prosodic features of pitch and volume reinforced with visual feedback [60], while another aims to maximize phonatory effort and loudness (the Lee Silverman Voice Treatment [LSVT-LOUD]) [61,63]. Patients should be directed to therapists trained in PD-specific methods for optimal benefit.

In practice, many individuals find improvements in their speech volume and prosody immediately after completing therapy; however, nonadherence to vocal exercises at home may lead to attrition of the initial benefits. As with physical and occupational therapy, patients should be encouraged to continue their speech therapy exercises at home to maintain their level of function and may benefit from periodic re-evaluations and refresher courses of these targeted and effective therapies.

OCCUPATIONAL THERAPY — As PD progresses, impairments in dexterity commonly affect a patient's ability to complete activities of daily living. Occupational therapists can work with patients to adapt certain activities, introduce assistive devices, and change the environment to foster safety and continued engagement in the activities a person enjoys. Most occupational therapy trials have been small; however, one randomized trial of 191 patients found a benefit in self-perceived performance of daily activities after three months [65].

MINDFULNESS AND MEDITATION — Various approaches aimed at cultivating or enhancing mindfulness, often incorporating meditation and/or yoga, have been studied in patients with PD [40,66-68]. This is an area of great interest among patients and care partners and of continued study among researchers, given the relative lack of side effects and potential benefits in self-efficacy, function, and social relationships. Mindfulness-based group therapy, delivered virtually, is both feasible and acceptable to patients with PD, and efficacy testing is underway [40,69].

NUTRITION — Older adults with chronic illness are at risk for poor nutrition, weight loss, bone loss, and decreased muscle mass. Patients with PD are specifically at increased risk of malnutrition and weight loss due to increased metabolic demands, anosmia and hypogeusia, dysphagia, and constipation [70]. These changes are associated with significant alterations in the gut microbiome in patients with PD [71].

Oropharyngeal dysphagia is prevalent in patients with PD, particularly at advanced stages. Swallowing problems impact nutrition and increase the risk of aspiration. Strategies to identify and treat dysphagia in patients with PD are reviewed separately. (See "Swallowing disorders and aspiration in palliative care: Definition, pathophysiology, etiology, and consequences" and "Swallowing disorders and aspiration in palliative care: Assessment and strategies for management".)

Healthy dietary habits over a longer period of time may help to prevent or slow progression of PD. One large cross-sectional study detected a difference in age of PD onset of up to 17 years among the highest adherers to the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) [72]. Earlier studies have also reported delayed progression of parkinsonism and a reduced incidence of cognitive impairment and Alzheimer disease associated with the MIND diet [73-75].

An analysis of the Nurses' Health Study and the Health Professionals Follow-Up Study among nearly 48,000 participants found that adherers to a healthy dietary pattern, including a Mediterranean-type diet, had a lower likelihood of reporting prodromal PD symptoms over time, such as depression, excessive daytime sleepiness, and constipation [76]. In this cohort and others, high adherers also had improved longevity after a diagnosis of PD [77].

While there are no consensus guidelines on a specific PD diet, certain recommendations can be made [78].

A high-fiber diet, adequate hydration, and regular exercise help manage the constipation of PD.

Large, high-fat meals that slow gastric emptying and interfere with medication absorption should be avoided.

The MIND diet may delay the onset and reduce the incidence and progression of parkinsonism.

Dietary protein restriction is not necessary except in some patients with advanced disease and motor fluctuations in whom competition with other amino acids interferes with L-dopa absorption. (See "Medical management of motor fluctuations and dyskinesia in Parkinson disease", section on 'Unpredictable "off" periods' and "Medical management of motor fluctuations and dyskinesia in Parkinson disease", section on 'Failure of "on" response'.)

There is no evidence at this time that large doses of vitamin E or other antioxidants are useful in PD [24].

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Parkinson disease".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Parkinson disease (The Basics)")

Beyond the Basics topics (see "Patient education: Parkinson disease treatment options — education, support, and therapy (Beyond the Basics)")

PATIENT PERSPECTIVE TOPIC — Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See "Patient perspective: Parkinson disease".)

SUMMARY

Education – Education is essential in order to provide the patient with Parkinson disease (PD) and family with some understanding and control over the disorder. In addition, the emotional and psychologic needs of the patient and family should be addressed. Support groups are a valuable resource (table 1). (See 'Education' above and 'Support' above.)

Social prescribing – Social isolation is associated with greater motor and nonmotor severity and poorer quality of life in PD. Referring individuals to community resources to promote social engagement and lifestyle modifications may be beneficial. (See 'Support' above.)

Exercise – Regular exercise and various physical therapy modalities appear to offer some benefit for improving function in patients with PD. (See 'Exercise and physical therapy' above.)

Speech therapy – Dysarthria and hypophonia are common manifestations of PD. Speech therapy may be helpful in improving speech volume and maintaining voice quality. (See 'Speech therapy' above.)

Nutrition – No specific diet influences the course of PD, but a high-fiber diet, adequate hydration, and regular exercise can help to reduce constipation associated with PD. Emerging evidence suggests the MIND diet may be associated with a lower risk of cognitive impairment. Large, high-fat meals that slow gastric emptying and interfere with medication absorption should be avoided. (See 'Nutrition' above.)

  1. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 2009; 72:S1.
  2. Maffoni M, Giardini A, Pierobon A, et al. Stigma Experienced by Parkinson's Disease Patients: A Descriptive Review of Qualitative Studies. Parkinsons Dis 2017; 2017:7203259.
  3. Chiong-Rivero H, Ryan GW, Flippen C, et al. Patients' and caregivers' experiences of the impact of Parkinson's disease on health status. Patient Relat Outcome Meas 2011; 2011:57.
  4. Vlaar A, Hovestadt A, van Laar T, Bloem BR. The treatment of early Parkinson's disease: levodopa rehabilitated. Pract Neurol 2011; 11:145.
  5. Carter JH, Stewart BJ, Archbold PG, et al. Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study Group. Mov Disord 1998; 13:20.
  6. Mittelman MS, Ferris SH, Shulman E, et al. A comprehensive support program: effect on depression in spouse-caregivers of AD patients. Gerontologist 1995; 35:792.
  7. Young Parkinson's Handbook, Mark MH, Sage JI (Eds), The American Parkinson Disease Association, Inc, New York 2000. www.stlapda.org/content/pdfs/Young%20Parkinson%20Handbook.pdf (Accessed on February 14, 2012).
  8. Haines S, Chen H, Anderson KE, et al. When do patients with Parkinson disease disclose their diagnosis? Neurology 2006; 67:488.
  9. Mathur DS, Mathur S, Mathur N, Mathur M. Shaky Hands - A Kid’s Guide To Parkinson’s Disease, CreateSpace Independent Publishing Platform, 2015.
  10. Mathur DS, Ali R. My GrandPa’s Shaky Hands, CreateSpace Independent Publishing Platform, 2014.
  11. Ali R. I’ll Hold Your Hand So You Won’t Fall: A Child’s Guide to Parkinson’s Disease, 1st ed, Merit, West Palm Beach 2010.
  12. Subramanian I, Farahnik J, Mischley LK. Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life. NPJ Parkinsons Dis 2020; 6:28.
  13. Santos-García D, Oreiro M, Pérez P, et al. Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients. Mov Disord 2020; 35:1712.
  14. Brown EG, Chahine LM, Goldman SM, et al. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease. J Parkinsons Dis 2020; 10:1365.
  15. Salari M, Zali A, Ashrafi F, et al. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic. Mov Disord 2020; 35:1095.
  16. Suran M. How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic. JAMA 2022; 327:801.
  17. Luis-Martínez R, Di Marco R, Weis L, et al. Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown. BMC Neurol 2021; 21:332.
  18. Bickerdike L, Booth A, Wilson PM, et al. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7:e013384.
  19. Roland M, Everington S, Marshall M. Social Prescribing - Transforming the Relationship between Physicians and Their Patients. N Engl J Med 2020; 383:97.
  20. Winter L, Gitlin LN. Evaluation of a telephone-based support group intervention for female caregivers of community-dwelling individuals with dementia. Am J Alzheimers Dis Other Demen 2006; 21:391.
  21. Moffatt S, Steer M, Lawson S, et al. Link Worker social prescribing to improve health and well-being for people with long-term conditions: qualitative study of service user perceptions. BMJ Open 2017; 7:e015203.
  22. Sennott B, Woo K, Hess S, et al. Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic. J Parkinsons Dis 2020; 10:1383.
  23. Comella CL, Stebbins GT, Brown-Toms N, Goetz CG. Physical therapy and Parkinson's disease: a controlled clinical trial. Neurology 1994; 44:376.
  24. Suchowersky O, Gronseth G, Perlmutter J, et al. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 66:976.
  25. Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol 2013; 70:183.
  26. Amara AW, Memon AA. Effects of Exercise on Non-motor Symptoms in Parkinson's Disease. Clin Ther 2018; 40:8.
  27. Amara AW, Wood KH, Joop A, et al. Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease. Mov Disord 2020; 35:947.
  28. Johansson ME, Cameron IGM, Van der Kolk NM, et al. Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial. Ann Neurol 2022; 91:203.
  29. Ridgel AL, Vitek JL, Alberts JL. Forced, not voluntary, exercise improves motor function in Parkinson's disease patients. Neurorehabil Neural Repair 2009; 23:600.
  30. Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology 2011; 77:288.
  31. Uc EY, Doerschug KC, Magnotta V, et al. Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting. Neurology 2014; 83:413.
  32. Reynolds GO, Otto MW, Ellis TD, Cronin-Golomb A. The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease. Mov Disord 2016; 31:23.
  33. Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev 2013; :CD002817.
  34. van der Kolk NM, de Vries NM, Kessels RPC, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial. Lancet Neurol 2019; 18:998.
  35. Schenkman M, Moore CG, Kohrt WM, et al. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol 2018; 75:219.
  36. Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med 2012; 366:511.
  37. Song R, Grabowska W, Park M, et al. The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis. Parkinsonism Relat Disord 2017; 41:3.
  38. Gow BJ, Hausdorff JM, Manor B, et al. Can Tai Chi training impact fractal stride time dynamics, an index of gait health, in older adults? Cross-sectional and randomized trial studies. PLoS One 2017; 12:e0186212.
  39. Vergara-Diaz G, Osypiuk K, Hausdorff JM, et al. Tai Chi for Reducing Dual-task Gait Variability, a Potential Mediator of Fall Risk in Parkinson's Disease: A Pilot Randomized Controlled Trial. Glob Adv Health Med 2018; 7:2164956118775385.
  40. Kwok JYY, Kwan JCY, Auyeung M, et al. Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol 2019; 76:755.
  41. Tomlinson CL, Herd CP, Clarke CE, et al. Physiotherapy for Parkinson's disease: a comparison of techniques. Cochrane Database Syst Rev 2014; :CD002815.
  42. Winser SJ, Tsang WW, Krishnamurthy K, Kannan P. Does Tai Chi improve balance and reduce falls incidence in neurological disorders? A systematic review and meta-analysis. Clin Rehabil 2018; 32:1157.
  43. Wade DT, Gage H, Owen C, et al. Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2003; 74:158.
  44. Monticone M, Ambrosini E, Laurini A, et al. In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial. Mov Disord 2015; 30:1050.
  45. Nonnekes J, Ružicka E, Nieuwboer A, et al. Compensation Strategies for Gait Impairments in Parkinson Disease: A Review. JAMA Neurol 2019; 76:718.
  46. Tosserams A, Wit L, Sturkenboom IHWM, et al. Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease. Neurology 2021.
  47. Miyai I, Fujimoto Y, Ueda Y, et al. Treadmill training with body weight support: its effect on Parkinson's disease. Arch Phys Med Rehabil 2000; 81:849.
  48. Miyai I, Fujimoto Y, Yamamoto H, et al. Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial. Arch Phys Med Rehabil 2002; 83:1370.
  49. Mehrholz J, Kugler J, Storch A, et al. Treadmill training for patients with Parkinson's disease. Cochrane Database Syst Rev 2015; :CD007830.
  50. Hirsch MA, Toole T, Maitland CG, Rider RA. The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson's disease. Arch Phys Med Rehabil 2003; 84:1109.
  51. Silva-Batista C, Corcos DM, Roschel H, et al. Resistance Training with Instability for Patients with Parkinson's Disease. Med Sci Sports Exerc 2016; 48:1678.
  52. Tollár J, Nagy F, Kovács N, Hortobágyi T. A High-Intensity Multicomponent Agility Intervention Improves Parkinson Patients' Clinical and Motor Symptoms. Arch Phys Med Rehabil 2018; 99:2478.
  53. Marchese R, Diverio M, Zucchi F, et al. The role of sensory cues in the rehabilitation of parkinsonian patients: a comparison of two physical therapy protocols. Mov Disord 2000; 15:879.
  54. Pacchetti C, Mancini F, Aglieri R, et al. Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med 2000; 62:386.
  55. Dos Santos Delabary M, Komeroski IG, Monteiro EP, et al. Effects of dance practice on functional mobility, motor symptoms and quality of life in people with Parkinson's disease: a systematic review with meta-analysis. Aging Clin Exp Res 2018; 30:727.
  56. Shanahan J, Morris ME, Bhriain ON, et al. Dancing for Parkinson Disease: A Randomized Trial of Irish Set Dancing Compared With Usual Care. Arch Phys Med Rehabil 2017; 98:1744.
  57. McDonnell MN, Rischbieth B, Schammer TT, et al. Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis. Clin Rehabil 2018; 32:607.
  58. Raymond MJ, Burge AT, Soh SE, et al. Experiences of older adults in a group physiotherapy program at a rehabilitation hospital: A qualitative study. J Hosp Med 2016; 11:358.
  59. Annesi JJ. Effects of a Group Protocol on Physical Activity and Associated Changes in Mood and Health Locus of Control in Adults with Parkinson Disease and Reduced Mobility. Perm J 2019; 23:18.
  60. Johnson JA, Pring TR. Speech therapy and Parkinson's disease: a review and further data. Br J Disord Commun 1990; 25:183.
  61. Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Mov Disord 2001; 16:79.
  62. Herd CP, Tomlinson CL, Deane KH, et al. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Cochrane Database Syst Rev 2012; :CD002812.
  63. Ramig L, Halpern A, Spielman J, et al. Speech treatment in Parkinson's disease: Randomized controlled trial (RCT). Mov Disord 2018; 33:1777.
  64. Pu T, Huang M, Kong X, et al. Lee Silverman Voice Treatment to Improve Speech in Parkinson's Disease: A Systemic Review and Meta-Analysis. Parkinsons Dis 2021; 2021:3366870.
  65. Sturkenboom IH, Graff MJ, Hendriks JC, et al. Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial. Lancet Neurol 2014; 13:557.
  66. Birtwell K, Dubrow-Marshall L, Dubrow-Marshall R, et al. A mixed methods evaluation of a Mindfulness-Based Stress Reduction course for people with Parkinson's disease. Complement Ther Clin Pract 2017; 29:220.
  67. Vandenberg BE, Advocat J, Hassed C, et al. Mindfulness-based lifestyle programs for the self-management of Parkinson's disease in Australia. Health Promot Int 2019; 34:668.
  68. Hawkins BL, Van Puymbroeck M, Walter A, et al. Perceived Activities and Participation Outcomes of a Yoga Intervention for Individuals with Parkinson's Disease: A Mixed Methods Study. Int J Yoga Therap 2018; 28:51.
  69. Bogosian A, Hurt CS, Hindle JV, et al. Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson's. J Geriatr Psychiatry Neurol 2022; 35:155.
  70. Mischley LK. Nutrition and Nonmotor Symptoms of Parkinson's Disease. Int Rev Neurobiol 2017; 134:1143.
  71. Cirstea MS, Yu AC, Golz E, et al. Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease. Mov Disord 2020; 35:1208.
  72. Metcalfe-Roach A, Yu AC, Golz E, et al. MIND and Mediterranean Diets Associated with Later Onset of Parkinson's Disease. Mov Disord 2021; 36:977.
  73. Agarwal P, Wang Y, Buchman AS, et al. MIND Diet Associated with Reduced Incidence and Delayed Progression of ParkinsonismA in Old Age. J Nutr Health Aging 2018; 22:1211.
  74. Morris MC, Tangney CC, Wang Y, et al. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement 2015; 11:1007.
  75. Hosking DE, Eramudugolla R, Cherbuin N, Anstey KJ. MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study. Alzheimers Dement 2019; 15:581.
  76. Molsberry S, Bjornevik K, Hughes KC, et al. Diet pattern and prodromal features of Parkinson disease. Neurology 2020; 95:e2095.
  77. Zhang X, Molsberry SA, Schwarzschild MA, et al. Association of Diet and Physical Activity With All-Cause Mortality Among Adults With Parkinson Disease. JAMA Netw Open 2022; 5:e2227738.
  78. Nutt JG, Carter JH. Dietary issues in the treatment of Parkinson's disease. In: Therapy of Parkinson's Disease, Koller WC, Paulson G (Eds), Marcel Dekker, New York 1990. p.531.
Topic 4899 Version 35.0

References